Disclosures
Disclosures
The plain statements behind this site, in one place.
Organization
NeuroClearance is a research and engineering program of NuvoNexus, operating within MNEOS. Contact: [email protected].
Program status
NeuroClearance builds research instruments for supervised studies. Its systems are investigational and under development; the current stage is a first bench unit for non-human testing. Any system intended for people will go through supervised studies under independent ethical oversight and, where required, an FDA Investigational Device Exemption, followed by regulatory review. Claims of benefit will follow the evidence and the regulators’ determination. As of this writing, NeuroClearance offers no product for sale, and no NeuroClearance system has been evaluated by any regulator for safety or effectiveness.
Educational content
The library summarizes published, third-party research for education, with sources listed on every article. It is general information, not medical advice; for personal medical decisions, talk with your clinician. Educational content describes the field and is not evidence about any NeuroClearance system.
Wellness products
Lullwave is a separate consumer wellness line, in development, that makes wellness claims only: calm, breathing practice and recovery. Lullwave products are general wellness products and are not medical devices.
Investment
NeuroClearance welcomes conversations with mission-aligned investors through Get involved. Investment discussions are held privately with qualified investors under separate documentation. Nothing on this site is an offer of securities.
Track record
References to the founder’s prior companies (Nuvotronics, Haleos, ACT MicroDevices) describe those companies and are not claims about NeuroClearance products, certifications or results.
Contact and health information
We read every message. Please keep personal health information out of messages to us; if any arrives, we delete it. See Privacy for how the site handles data.
Patents
Technical specifics of the program are described publicly as results are ready for review. Patent status is stated on this site only after review by counsel.